Beckman Coulter Diagnostics Acquires StoCastic LLC

Castle Biosciences Acquires Cernostics

October 19, 2021

Healthcare Services

Castle Biosciences (Nasdaq: CSTL) has completed the acquisition of Cernostics, Inc., a Pittsburgh-based developer of the TissueCypher spatial biology and AI-driven image analysis platform, for approximately $30 million in initial consideration plus up to $50 million in performance-based milestones. The deal brings the TissueCypher Barrett's Esophagus Assay into Castle's portfolio, expanding the company's diagnostics capabilities into the gastrointestinal and oncology markets and adding an estimated ~$1 billion to Castle's U.S. TAM.

Cornell Capital and Trilantic North America Acquire trustaff and CardioSolution and Agree to Acquire Stella to Create Tech-Enabled Healthcare Staffing Platform

February 8, 2021

Healthcare Services

Cornell Capital LLC and Trilantic North America have acquired trustaff Management, Inc. and CardioSolution and agreed to acquire Stella.ai, combining the three companies into a technology-enabled healthcare staffing platform. The PE sponsors plan to accelerate growth through data science, automation and management-led expansion while retaining key management and board participation.

Ott Scientific Acquires American Bionostica

April 1, 2021

Medical Devices

Ott Scientific has acquired American Bionostica, Inc., a developer and manufacturer of specialty lateral flow assays; the acquisition was effective April 1 and ABI will operate inside Ott Scientific’s Ethos Biosciences subsidiary. The American Bionostica team will join Ott Scientific, with expanded research and production capacity planned at Ott Scientific’s new ISO13485/cGMP space in Logan Township, New Jersey.

StemBioSys Acquires Majority Stake in Cartox

January 8, 2020

Biotechnology

San Antonio-based StemBioSys acquired a majority stake in Ann Arbor startup Cartox, obtaining control with plans to purchase the remaining equity subject to milestones. The deal brings Cartox's cardiotoxicity imaging and assay capabilities together with StemBioSys's CELLvo extracellular matrix technology to accelerate commercial development of pre-clinical cardiac safety and efficacy screening solutions.

JMD Properties, Inc. Acquires Stella Diagnostics

September 2, 2020

Biotechnology

JMD Properties, Inc. announced the acquisition of Stella Diagnostics, LLC via a preferred stock transaction and will change its corporate name to Stella Diagnostics, Inc. The deal positions the public company to pivot into the molecular diagnostics / biotech sector to commercialize Stella’s oncology-focused assays for esophageal disease.

Operative Acquires Ad Tech Firm STAQ

March 16, 2021

Data & Analytics

Operative has completed the acquisition of STAQ, a data collection, normalization and visualization technology company that automates aggregation of revenue and inventory data from hundreds of sources. The deal expands Operative's data and programmatic business-management capabilities—integrating STAQ's data processing and visualization into Operative's AOS platform to provide unified, automated insights for media companies and marketers.